Miyake Y, Nishimoto Y
Developmental Research Laboratories, Shionogi & Co., Ltd., Osaka, Japan.
J Toxicol Sci. 1998 Oct;23 Suppl 4:613-8. doi: 10.2131/jts.23.supplementiv_613.
Disodium mercaptoundecahydro-closo-dodecaborate (BSH) was studied for mutgenic potential by reverse mutation test with bacteria. The test was carried out using five different tester strains, S. typhimurium TA100, TA1535, TA98 and TA1537, and E. coli WP2uvrA by the preincubation method. BSH was tested at concentrations ranging from 156 to 5000 micrograms per plate. The test substance did not induce revertants dose-dependently in any strains with or without a metabolic activation system. Therefore, it was concluded that BSH was not mutagenic in the present reverse mutation test.
通过细菌回复突变试验研究了巯基十一氢-闭式-十二硼酸钠(BSH)的致突变潜力。采用预培养法,使用五种不同的测试菌株,即鼠伤寒沙门氏菌TA100、TA1535、TA98和TA1537以及大肠杆菌WP2uvrA进行了该试验。BSH的测试浓度范围为每平板156至5000微克。无论有无代谢活化系统,受试物质在任何菌株中均未剂量依赖性地诱导回复突变体。因此,得出结论,在本次回复突变试验中,BSH无致突变性。